四种氨基酸增加十二指肠刷状缘膜囊泡中DMT1丰度并增强缺铁小鼠的铁吸收
研究筛选20种氨基酸,发现天冬氨酸、谷氨酰胺、谷氨酸和甘氨酸组成的四氨基酸配方可增加缺铁小鼠十二指肠肠上皮细胞刷状缘膜DMT1蛋白丰度约1.5倍,增强体内59Fe吸收约2倍,且该作用依赖肠道DMT1。
要点
- 四种氨基酸(Asp、Gln、Glu、Gly)使小鼠十二指肠上皮片59Fe转运增加约4倍(P < .05)。
- 缺铁小鼠口服四氨基酸配方后肠上皮刷状缘膜DMT1蛋白丰度增加约1.5倍(P < .05)。
- 四氨基酸配方使缺铁小鼠体内59Fe吸收增强约2倍(P < .05),且依赖肠道DMT1。
核心结论
- 特定氨基酸通过诱导DMT1转运至十二指肠肠上皮细胞顶端膜来增强铁吸收。
- 作者推测进一步优化该四氨基酸配方最终将允许以更低有效剂量补铁,从而减轻过量肠内铁的负面副作用。
研究设计与样本
- 采用离体十二指肠环/DMT1蛋白质印迹法筛选全部20种氨基酸。
- 选择Asp、Gln、Glu和Gly四种氨基酸组合成新配方进行后续实验。
- 使用Ussing chamber中小鼠十二指肠上皮片评估59Fe转运。
- 在缺铁小鼠中经口灌胃四氨基酸配方,评估DMT1蛋白丰度和体内59Fe吸收。
- 使用DMT1int/int小鼠验证肠道DMT1在四氨基酸诱导铁转运中的作用。
主要发现
- 四种氨基酸刺激小鼠十二指肠上皮片59Fe转运约4倍(P < .05)。
- 缺铁小鼠口服四氨基酸配方后肠上皮刷状缘膜DMT1蛋白丰度增加约1.5倍(P < .05)。
- 四氨基酸配方使缺铁小鼠体内59Fe吸收增强约2倍(P < .05),即使转运溶液中包含约26 µg冷铁(相当于人体剂量约73 mg)。
- DMT1int/int小鼠实验表明肠道DMT1是四氨基酸诱导铁转运所必需的。
关键数值与推荐
- 四种氨基酸为Asp、Gln、Glu和Gly。
- 59Fe转运增加约4倍(P < .05)。
- DMT1蛋白丰度增加约1.5倍(P < .05)。
- 体内59Fe吸收增强约2倍(P < .05)。
- 转运溶液中包含约26 µg冷铁,相当于人体剂量约73 mg。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Iron-deficiency anemia is common worldwide and typically treated by oral iron supplementation. Excess enteral iron, however, may cause pathological outcomes. Developing new repletion approaches is thus warranted. Previous experimentation revealed that select amino acids (AAs) induce trafficking of transporters onto the enterocyte brush-border membrane (BBM) and enhance electrolyte absorption/secretion. Here, we hypothesized that certain AAs would increase the abundance of the main intestinal iron importer, divalent metal-ion transporter 1 (DMT1), on the BBM of duodenal enterocytes, thus stimulating iron absorption. Accordingly, all 20 AAs were screened using an ex vivo duodenal loop/DMT1 western blotting approach. Four AAs (Asp, Gln, Glu, and Gly) were selected for further experimentation and combined into a new formulation. The 4 AAs stimulated 59Fe transport in mouse duodenal epithelial sheets in Ussing chambers (∼4-fold; P < .05). In iron-deprived mice, oral intragastric administration of the 4 AA formulation increased DMT1 protein abundance on the enterocyte BBM by ∼1.5-fold (P < .05). The 4 AAs also enhanced in vivo 59Fe absorption by ∼2-fold (P < .05), even when ∼26 µg of cold iron was included in the transport solution (equal to a human dose of ∼73 mg). Further experimentation using DMT1int/int mice showed that intestinal DMT1 was required for induction of iron transport by the 4 AAs. Select AAs thus enhance iron absorption by inducing DMT1 trafficking onto the apical membrane of duodenal enterocytes. We speculate that further refinement of this new 4 AA formulation will ultimately allow iron repletion at lower effective doses (thus mitigating negative side effects of excess enteral iron).
引用
- Woloshun RR, Yu Y, Xu X, et al. Four AAs increase DMT1 abundance in duodenal brush-border membrane vesicles and enhance iron absorption in iron-deprived mice. Blood Adv. 2022. PMID: 35061889. doi:10.1182/bloodadvances.2021005111
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。